Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows

v3.20.1
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash Flows from Operating Activities:    
Net loss $ (3,281) $ (5,890)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 639 798
Issuance of common shares - Founders Agreement 0 9
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 110 308
Other receivables - related party (946) 1,455
Accounts payable and accrued expenses (1,062) (4,883)
Net cash used in operating activities (4,540) (8,203)
Cash Flows from Financing Activities:    
Issuance of common shares - At-the-market offering 0 365
Offering costs for the issuance of common shares - At-the-market offering 0 (10)
Offering costs for the issuance of common shares - Public offering (69) 0
Proceeds from the exercise of warrants 13 0
Net cash (used in) provided by financing activities (56) 355
Net decrease in cash and cash equivalents (4,596) (7,848)
Cash and cash equivalents at beginning of period 26,077 21,995
Cash and cash equivalents at end of period 21,481 14,147
Supplemental disclosure of noncash investing and financing activities:    
Issuance of common shares - Founders Agreement $ 0 $ 1,748